Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications; D000641:Ammonia / Q000097:blood; D001927:Brain Diseases / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003106:Colon / Q000382:microbiology; D004044:Dietary Proteins; D004187:Disaccharides / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004569:Electroencephalography; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007422:Intestines / Q000382:microbiology; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy*; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D009461:Neurologic Manifestations; D013012:Sorbitol / Q000627:therapeutic use
D004044:Dietary Proteins; D004187:Disaccharides; D013012:Sorbitol; D000641:Ammonia; D009355:Neomycin